Cigna Will Stop Covering OxyContin in Effort to Reduce Inappropriate Use

Health insurer Cigna announced this week it will stop covering the prescription opioid OxyContin in an effort to reduce inappropriate use of the drug. Instead it will cover an equivalent drug less vulnerable to being misused.

The alternate drug is Xtampza ER, made by Collegium Pharmaceutical Inc. Xtampza ER cannot be made more fast-acting through cutting or crushing, Cigna said. The change will go into effect January 1, 2018, Reuters reports.

Full story at drugfree.org